Device Trial Radar · NCT07680543
ProVIDE Studies Post Exit Analysis
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
25
Planned (sponsor's estimate)
Start
Sep 30, 2026
Primary completion
Jul 31, 2029
Study completion Jul 31, 2029
Sponsor
- Lead sponsor
- ProVerum MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 2, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Male only, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study to collect data on the post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.
Conditions
- BPH With Symptomatic Lower Urinary Tract Symptoms
Interventions
ProVee Urethral Expander SystemDevice
ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Post-study exit incidence of secondary reintervention using alternate surgical LUTS therapy.Time frame: Up to 36 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Comprehensive Urologic Care
Lake Barrington, Illinois · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.